37 They can be described as moderate to severe and persistent
Comprehensive testing includes encapsulation efficiency, particle size uniformity, zeta potential, and preliminary release kinetics
The first three peptides (GHK-Cu, BPC-157, TB-500) and their amounts (50mg, 10mg, 10mg) are identical between GLOW and KLOW
Starting with lower doses and gradually increasing can help minimize any gastrointestinal adjustment
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide, meaning a chain of 15 amino acids, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
To view a copy of this licence, visit About this article Cite this article Xiao, Y., Wang, W., Wang, G